Cold agglutinin disease secondary to severe SARS-CoV-2 treated with eculizumab

Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection

(2021) Michael J. Christie et al.   Science Immunology

Autoimmune haemolytic anaemia associated with COVID‐19 infection

(2020) Gregory Lazarian et al.   BRITISH JOURNAL OF HAEMATOLOGY

Immune Thrombocytopenic Purpura in a Patient with Covid-19

(2020) Abrar-Ahmad Zulfiqar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases

(2020) Cynthia Magro et al.   Translational Research

New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia

(2020) Sigbjørn Berentsen   Frontiers in Immunology

Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report

(2020)   NEW ENGLAND JOURNAL OF MEDICINE

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

(2019) Alexander Röth et al.   BLOOD

Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial

(2018) Ulrich Jäger et al.   BLOOD

Cold agglutinin disease

(2016) S. Berentsen   Hematology-American Society of Hematology Education Program

Cholangiocarcinoma Presenting as Metastases to the Cervical Spine

(2011) Trilokesh Kidambi et al.   AMERICAN JOURNAL OF MEDICINE